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There are several benign prostatic pathologies that can clinically mimic a prostate adenocarcinoma.
Xanthogranulomatous prostatitis is a benign inﬂammatory condition of the prostate and a rare entity. A
47-year old male, with 3 years of lower urinary tract symptoms, with a palpable hypogastric tumor,
digital rectal examination: solid prostate, of approximately 60 g. Initial PSA was 0.90 ng/mL. He un-
derwent surgical excision of the lower abdominal nodule and prostatectomy. Histopathology showed
xanthogranulomatous prostatitis, without malignancy. Xanthogranulomatous prostatitis is an extremely
rare entity that can simulate prostate adenocarcinoma, therefore having a correct histopathological
diagnosis is essential.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The benign pathologies of the prostate that can mimic a pros-
tatic adenocarcinoma are compromised in six grand groups, and
among them we ﬁnd the inﬂammatory pathologies. Xanthogranu-
lomatous prostatitis is considered among those pathologies and can
clinically behave as a prostatic carcinoma. The ﬁrst case report and
description of this pathology was made in Poland by Miekos et al1
in 1986, and 15 cases have been reported in worldwide literature
since, the most recent ones in India2 and South Korea.3 In this
article, we present a case report of a patient with clinical suspicion
of prostatic carcinoma and histopathological report of xanthogra-
nulomatous prostatitis.Case presentation
47 year old male patient, who started 3 years ago of lower
urinary tract symptoms, urinary incontinence, urgency, reduced
urinary stream, frequency 8/4, and acute urinary retention mul-
tiple times. As comorbidity the patient has diagnosis of chronic
kidney disease on hemodialysis as renal replacement therapy
with 3 sessions per week. Digital rectal examination, found a
hard prostate, of approximately 60 g, abdominal tenderness, noyolalejandro@gmail.com
Inc. This is an open access article uthat presented with a tumor in the lower abdomen, mobile, not
ﬁxed. Previously presented with bulbar urethral stenosis and a
history of internal urethrotomy and transurethral resection of the
prostate, with initial pathology report of benign prostatic
hyperplasia.
Afterward our patient continued to have lower urinary tract
symptoms and he underwent resection of tumor and open pros-
tatectomy, with the following ﬁndings: 3  3 cm tumor in the
bladder dome, hard prostate and multiple fetid clots inside the
bladder. He had an initial prostatic speciﬁc antigen of 0.94 ng/mL
in September 2012 and his last prostatic speciﬁc antigen dated
01/27/15 was 0.40 ng/mL. Currently our patient has spontaneous
micturition and still has renal replacement therapy with
hemodialysis.
The histopathological report showed the lower abdomen
tumor was a bladder leiomyoma and prostate with xanthogra-
nulomatous prostatitis, with glands of multiple sizes, abundant
ﬁbrous stroma with a chronic inﬂammatory inﬁltrate rich with
lymphocytes, plasma cells and histiocytes and no evidence of
malignancy.
Discussion
Granulomatous lesions of the prostate remain rare and their
classiﬁcation is controversial. Some etiologic agent has been pro-
posed for granulomatous prostatitis including some fungi, Trepo-
nema pallidum and Mycobacterium tuberculosis. Non-speciﬁc
granulomatous prostatitis remains the most frequent diagnosis in
terms granulomatous prostatitis.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Xanthogranulomatous prostatitis.
Figure 2. Histiocytes.
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suggested.
In xanthogranulomatous prostatitis, histiocytes are observed
in large amounts in an inﬂammatory inﬁltrate, that is
accompanied by multiple lymphocytes and plasma cells. This
speciﬁc feature, the histiocytes, cause confusion and may be
diagnosed as prostate adenocarcinoma with hypernephroid
pattern (Gleason 4B).4
Generally this condition, xantogranulomatosis, is observed
more frequently in the kidney and the gallbladder and very rarely
in the prostate.5 The age of diagnosis is usually the sixth decade of
life but it has a wide range. Clinically they have low obstructive
urinary symptoms and digital rectal examination, with a palpable
hard prostate and which may make differentiation of prostatic
carcinoma difﬁcult. It has been observed in some studies a range of
prostatic speciﬁc antigen from 0.5 ng/mL to 150 ng/mL. In the
present study, the patient prostatic speciﬁc antigen was elevated
and its range was 0.40 ng/mL to 90 ng/mL with an average of
0.65 ng/mL.
Currently no imaging study allows for differentiation between
this condition and prostatic adenocarcinoma. The diagnosis is his-
topathologic (Figs. 1, 2).Conclusion
Xanthogranulomatous prostatitis is an extremely rare entity and
can simulate either clinically and/or biochemically a prostatic
adenocarcinoma. Precise histopathologic diagnosis has and will
have the outmost importance for differentiating benign from ma-
lignant prostatic pathology.
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